posted on 2019-06-27, 00:00authored byJie Cao, Jinnan Chi, Junfei Xia, Yanru Zhang, Shangcong Han, Yong Sun
Phototheranostics,
which combines deep tissue imaging and phototherapy
[photodynamic therapy (PDT) and/or photothermal therapy (PTT)] via
light irradiation, is a promising strategy to treat tumors. Near-infrared
(NIR) cyanine dyes are researched as potential phototheranostics reagents
for their excellent photophysical properties. However, the low singlet
oxygen generation efficiency of cyanine dyes often leads to inadequate
therapeutic efficacy for tumors. Herein, we modified an indocyanine
green derivative Cy7 with heavy atom iodine to form a novel NIR dye
CyI to improve the reactive oxygen species (ROS) production and heat
generation while, at the same time, maintain their fluorescence characteristics
for in vivo noninvasive imaging. More importantly, in vitro and in
vivo therapeutic results illustrated that CyI could quickly and simultaneously
generate enhanced ROS and heat to induce more cancer cell apoptosis
and higher inhibition rates in deep HepG2 tumors than other noniodinated
NIR dyes upon NIR irradiation. Besides, low toxicity of the resulted
iodinated NIR dyes was confirmed by in vivo biodistribution and acute
toxicity. Results indicate that this low toxic NIR dye could be an
ideal phototheranostics agent for deep tumor treatments. Our study
presents a novel approach to achieve the fast-synergistic PDT/PTT
treatment in deep tissues.